A new study found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US when compared with prices in the United Kingdom, Japan and the Canadian province of Ontario. The study also found that the longer the brand-name prescription drug was on the market, the greater the price differential.
